Application of Deuterated N, N-Dimethyltryptamine in the Potential Treatment of Psychiatric and Neurological Disorders

Affiliations

Editorial

Robert B Kargbo. ACS Med Chem Lett. 2022.

. 2022 Aug 22;13(9):1402-1404.

doi: 10.1021/acsmedchemlett.2c00354. eCollection 2022 Sep 8.

No abstract available

Conflict of interest statement

The author declares no competing financial interest.

1. James E.; Keppler J.; L Robertshaw T.; Sessa B. N,N-Dimethyltryptamine and Amazonian ayahuasca plant medicine. Hum. Psychopharmacol. 2022, 37, e2835. 10.1002/hup.2835. - DOI - PMC - PubMed
1. Barker S. A. Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT. Psychopharmacology 2022, 239, 1749. 10.1007/s00213-022-06065-0. - DOI - PMC - PubMed
1. McClure-Begley T. D.; Roth B. L. The promises and perils of psychedelic pharmacology for psychiatry. Nat. Rev. Drug Discovery 2022, 21, 463. 10.1038/s41573-022-00421-7. - DOI - PubMed
1. Vorobyeva N.; Kozlova A. A. Three naturally occurring psychedelics and their significance in the treatment of mental health disorders. Front. Pharmacol. 2022, 13, 927984. 10.3389/fphar.2022.927984. - DOI - PMC - PubMed
1. Cameron L. P.; Benson C. J.; DeFelice B. C.; Fiehn O.; Olson D. E. Chronic, intermittent microdoses of the psychedelic N,N-dimethyltryptamine (DMT) produce positive effects on mood and anxiety in rodents. ACS Chem. Neurosci. 2019, 10, 3261. 10.1021/acschemneuro.8b00692. - DOI - PMC - PubMed